{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:19:22Z","timestamp":1787750362817,"version":"build-2784847793"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5]]},"abstract":"Abstract<\/jats:title>\n \n Introduction:<\/jats:title>\n Fibrocalculous pancreatic diabetes (FCPD) is a unique form of diabetes characterised by irreversible damage to the pancreatic parenchyma with intraductal calcification, progressively leading to beta-cell damage. The classical clinical presentation of FCPD is evolving, with a declining frequency of typical phenotypes and increasing involvement of individuals with normal BMI and older age at presentation. This Study evaluated the clinical and demographic profile of patients with FCPD in North Karnataka and compared the glycaemic response to pioglitazone.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n This was a single-centre retrospective observational study done at a tertiary care endocrinology centre. Patients with FCPD diagnosed between December 2019 and December 2024 were retrospectively analysed. Clinical characteristics, imaging and glycaemic data were collected. Patients with suboptimal glycaemic control despite insulin therapy (HbA1c >9%) were initiated on add-on pioglitazone or metformin, and within-group changes in HbA1c and daily insulin requirement over 3 months were evaluated using paired\n t<\/jats:italic>\n -tests.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n The mean age at diagnosis was 42 \u00b1 11.97 years, with a mean diagnostic delay of 2.83 \u00b1 1.8 years. Only 10.5% of patients were correctly diagnosed with FCPD at initial presentation. Despite receiving insulin therapy, 76.5% of patients experienced progressive weight loss, and 76.8% reported frequent hypoglycaemic episodes.<\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n FCPD in North Karnataka demonstrated atypical clinical features (low BMI and chronic diarrhoea) with delayed diagnosis and frequent hypoglycaemia. Glycaemic control could be optimised with short-acting insulin. Pioglitazone compared with metformin significantly improved glycaemic parameters and reduced insulin requirement, due to its effect on hepatic insulin resistance.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijem.ijem_784_25","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T14:02:09Z","timestamp":1782482529000},"page":"223-227","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Fibrocalculous Pancreatic Diabetes: Changing Clinical Spectrum and Glycaemic Response to Pioglitazone"],"prefix":"10.4103","volume":"30","author":[{"given":"Don","family":"David","sequence":"first","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (Deemed to be University), Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjunath","family":"Goroshi","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (Deemed to be University), Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanishri","family":"Ganakumar","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (Deemed to be University), Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikrant","family":"Ghatnatti","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Nehru Medical College, KLE Academy of Higher Education and Research (Deemed to be University), Belagavi, Karnataka, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"R1-20260626","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s13410-018-0638-x","article-title":"Fibrocalculous pancreatic diabetes\u2014current scenario in developing countries","volume":"38","author":"Praveen","year":"2018","journal-title":"Int J Diabetes Dev Ctries"},{"key":"R2-20260626","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/1753-0407.12280","article-title":"Emerging concepts in the pathogenesis of diabetes in fibrocalculous pancreatic diabetes","volume":"7","author":"Dasgupta","year":"2015","journal-title":"J Diabetes"},{"key":"R4-20260626","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1086\/342731","article-title":"SPINK1 is a susceptibility gene for fibrocalculous pancreatic diabetes in subjects from the Indian subcontinent","volume":"71","author":"Hassan","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R5-20260626","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1136\/jmg.39.5.347","article-title":"Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI\/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis","volume":"39","author":"Chandak","year":"2002","journal-title":"J Med Genet"},{"key":"R6-20260626","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.dsx.2019.03.003","article-title":"A comparative study of the clinical profile of fibrocalculous pancreatic diabetes and type 2 diabetes mellitus","volume":"13","author":"Shivaprasad","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"R7-20260626","first-page":"762","article-title":"A clinical profile of fibrocalculous pancreatic diabetes patients from eastern India with special reference to body fat percentage and insulin resistance","volume":"107","author":"Singla","year":"2009","journal-title":"J Indian Med Assoc"},{"key":"R8-20260626","doi-asserted-by":"crossref","first-page":"580","DOI":"10.4103\/ijem.IJEM_297_19","article-title":"The clinical spectrum of fibrocalculous pancreatic diabetes in Kashmir valley and comparative study of the clinical profile of fibrocalculous pancreatic diabetes and type 2 diabetes mellitus","volume":"23","author":"Bhat","year":"2019","journal-title":"Indian J Endocrinol Metab"},{"issue":"(Suppl_1)","key":"R9-20260626","first-page":"S1","article-title":"Introduction and methodology: Standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"issue":"(Suppl 1)","key":"R10-20260626","first-page":"S20","article-title":"Classification and diagnosis of diabetes: Standards of care in diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"issue":"(Suppl_1)","key":"R11-20260626","first-page":"S231","article-title":"12. Retinopathy, neuropathy, and foot care: Standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"issue":"(Suppl_1)","key":"R12-20260626","first-page":"S219","article-title":"11. Chronic kidney disease and risk management: Standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"R13-20260626","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"R14-20260626","first-page":"511","article-title":"Fibro-calculous pancreatic diabetes","volume":"8","author":"Mohan","year":"1985","journal-title":"Diabetes Care"},{"key":"R15-20260626","first-page":"496","article-title":"Fibrocalculous pancreatic diabetes","volume":"78","author":"Chowdhury","year":"2002","journal-title":"Postgrad Med J"},{"key":"R16-20260626","first-page":"213","article-title":"Insulin sensitivity indices and their correlation with fasting insulin levels in fibrocalculous pancreatic diabetes","volume":"42","author":"Mohan","year":"1998","journal-title":"Diabetes Res Clin Pract"},{"key":"R17-20260626","first-page":"1099","article-title":"Chronic pancreatitis in children in southern India","volume":"21","author":"Ramakrishna","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"R18-20260626","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3350\/cmh.2020.0137","article-title":"Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease","volume":"26","author":"Kim","year":"2020","journal-title":"Clin Mol Hepatol"},{"key":"R19-20260626","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa060326","article-title":"A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis","volume":"355","author":"Belfort","year":"2006","journal-title":"N Engl J Med"},{"key":"R20-20260626","first-page":"625","article-title":"Impaired insulin action in non-obese patients with fibrocalculous pancreatic diabetes","volume":"33","author":"Yajnik","year":"1990","journal-title":"Diabetologia"},{"key":"R21-20260626","first-page":"141","article-title":"Comparative analysis of glycemic and metabolic parameters of patients with fibrocalculous pancreatic diabetes and type 2 diabetes mellitus: A systematic review and meta-analysis","volume":"45","author":"Sinha","year":"2025","journal-title":"Int J Diabetes Dev Ctries"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_784_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T12:27:26Z","timestamp":1787747246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_784_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_784_25","relation":{},"ISSN":["2230-8210","2230-9500"],"issn-type":[{"value":"2230-8210","type":"print"},{"value":"2230-9500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"2025-08-09","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}